covid-19
Ivermectin – COVID-19 Treatment Guidelines
Ivermectin has been shown to inhibit the replication of SARS-CoV-2 in cell cultures.13 However, pharmacokinetic and pharmacodynamic studies suggest that achieving the plasma concentrations necessary for the antiviral efficacy detected in vitro would require administration of doses up to 100-fold higher than those approved for use in humans.
Why You Should Not Use Ivermectin to Treat or Prevent COVID-19
Monoclonal antibodies: Overburdened hospitals are not offering this treatment against covid-19
Found: genes that sway the course of the coronavirus
Inspired by llamas, scientists make potent anti-coronavirus agent
Confusion spreads over selection of priority groups for Covid-19 vaccines
On Tuesday, the National Academy of Medicine, tasked by top U.S. health officials, named an expert panel to develop a framework to determine who should be vaccinated first, when available doses are expected to be scarce. But that panel is ostensibly encroaching on the role of the Advisory Committee on Immunization Practices, a panel that has made recommendations on vaccination policy to the Centers for Disease Control and Prevention for decades, including drawing up the vaccination priority list during the 2009 H1N1 flu pandemic.
What Does It Mean to Say a New Drug ‘Works’?
In the midst of a global crisis, scientists are trying to solve an epistemologically intractable question. Defining whether a drug “works” has never been easy, a task vexed by methodological uncertainty, commercial pressures, statistical errors, or sometimes straight-out bad practices. Facing a new disease, researchers have to rethink what success even means. Is it lower mortality? Less disability upon recovery? Faster recovery? The answers are cryptic because the questions are just educated guesses.
Coronavirus Drug and Treatment Tracker
Decades of research on an HIV vaccine boosts the bid for one against coronavirus
Those decades of research into HIV have taught scientists an enormous amount about the immune system, honed vaccine technologies now being repurposed against the coronavirus and created a worldwide infrastructure of clinical trial networks that can be pivoted from HIV to the pathogen that causes the disease covid-19.
Moderna coronavirus vaccine shows promising results in early clinical trial
An experimental coronavirus vaccine developed by Moderna provoked an immune response without major side effects in an early-stage clinical trial, scientists reported Tuesday in the New England Journal of Medicine.The vaccine is the first developed by a U.S. company to publish clinical trial results.
Regeneron Starts Phase 3 Trial For Coronavirus Antibody Cocktail
Regeneron Pharmaceuticals has started late-stage clinical trials evaluating REGN-COV2, its investigational double antibody cocktail for the treatment and prevention of COVID-19. A Phase 3 trial will evaluate REGN-COV2's ability to prevent infection among uninfected people who have had close exposure to a COVID-19 patient.
Remdesivir: How does the drug treat coronavirus and is it available in the UK?
Health officials in the US have announced that the Trump administration has bought almost the entire world’s stock of the Covid-19 drug remdesivir. Despite its ability to shorten the recovery times (by around four days) of some coronavirus patients, remdesivir has not been found to significantly improve an individual’s chances of surviving the disease.
Virology and physics join forces to beat COVID-19
Coronavirus: Dexamethasone proves first life-saving drug
A cheap and widely available drug can help save the lives of patients seriously ill with coronavirus. The low-dose steroid treatment dexamethasone is a major breakthrough in the fight against the deadly virus, UK experts say. The drug is part of the world's biggest trial testing existing treatments to see if they also work for coronavirus.
Researchers Are Looking Into Alternatives To Remdesivir In The Coronavirus Treatment
Cuba credits two drugs with slashing coronavirus death toll
Israeli scientists discover monoclonal antibody that neutralizes SARS-CoV-2
In a significant medical breakthrough, Israel's Institute for Biological Research Institute (IIBRI) has wrapped up the development of a potential treatment for the coronavirus disease. The scientists say they have identified an antibody that neutralizes SARS-CoV-2 in vitro or outside of a living organism.
What You Should Know About Remdesivir, The Potential COVID-19 Treatment
On Wednesday, researchers announced that they had “positive data” in regards to a potential treatment for COVID-19. Clinical trials for Gilead Sciences’ antiviral drug remdesivir, which was developed to treat Ebola, showed a “clear-cut positive effect in diminishing time to recover,” according to Dr. Anthony Fauci, the director of the National Institute of Allergy and Infectious Diseases.
Can Estrogen and Other Sex Hormones Help Men Survive Covid-19?
As the novel coronavirus swept through communities around the world, preying disproportionately on the poor and the vulnerable, one disadvantaged group has demonstrated a remarkable resistance. Women, whether from China, Italy or the U.S., have been less likely to become acutely ill — and far more likely to survive. Which has made doctors wonder: Could hormones produced in greater quantities by women be at work?